Drug Trial Radar · NCT07476287
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
Jul 2, 2026
Primary completion
Mar 24, 2028
Study completion Mar 24, 2031
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Mar 17, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is being done to learn more about a new medicine called PF-08634404. The study team wants to understand how well PF-08634404 works when given alone or with chemotherapy . Chemotherapy is a type of cancer treatment that uses medicines to destroy cancer cells or stop them from growing. The study is for adults with Transformed Small Cell Lung Cancer (T-SCLC ). T SCLC is a rare lung cancer that happens when one type of lung cancer changes into a more aggressive type after treatment stops working. To join the study, participants must meet the following conditions: * Are aged 18 years or older * Diagnosed with T-SCLC and have not received treatment for this type of lung cancer (a single cycle of chemotherapy may be permitted) * Prior diagnosis of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer treated with tyrosine kinase inhibitors (TKIs) * Have healthy organs based on medical tests and are in good physical condition After joining the study, adults will be given chemotherapy in addition to the study medicine. After this combination treatment is finished, the study medicine will be continued alone. Adults will receive the treatment through IV infusions (medicine given directly into a vein). All treatments will be done at clinical study sites, where a trained medical team will monitor adults during and after each visit.
Conditions
- Small Cell Lung Cancer
- Small Cell Lung Cancer ( SCLC )
- Transformed Small Cell Lung Cancer
- Lung Neoplasms
- Carcinoma, Small Cell Lung
- Small Cell Cancer Of The Lung
Interventions
PF-08634404Drug
Concentrate for solution for infusion
ChemotherapyDrug
Injection for intravenous use
Primary outcomes
What the sponsor says the trial is designed to measure.
- Confirmed Objective Response Rate (ORR) as assessed by investigator based on Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST v1.1)Time frame: From start of treatment until first documented CR or PR (approximately maximum up to 1 years)
- Number of Participants with Adverse Events (AEs)Time frame: Up to 90 days after the last dose of treatment
Locations
75 sites in 12 countries. Site status is shown where the registry gives one.
City of Hope National Medical Center
Duarte, California · Recruiting
UC San Diego Medical Center - Encinitas
Encinitas, California · Recruiting
City of Hope Lennar Foundation Cancer Center
Irvine, California · Recruiting
UC San Diego Koman Family Outpatient Pavilion
La Jolla, California · Recruiting
UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Pavilion)
La Jolla, California · Recruiting
UC San Diego Moores Cancer Center
La Jolla, California · Recruiting
UC San Diego Sulpizio Cardiovascular Center
La Jolla, California · Recruiting
UC San Diego Medical Center - Bankers Hill
San Diego, California · Recruiting
UC San Diego McGrath Outpatient Pavilion - Hillcrest
San Diego, California · Recruiting
UC San Diego Medical Center- Hillcrest
San Diego, California · Recruiting
UC San Diego Medical Center - Rancho Bernardo
San Diego, California · Recruiting
UC San Diego Medical Center - Vista
Vista, California · Recruiting
Sylvester Comprehensive Cancer Center - The Lennar Foundation Medical Center
Coral Gables, Florida · Recruiting
Sylvester Comprehensive Cancer Center- Doral
Doral, Florida · Recruiting
Sylvester Comprehensive Cancer Center
Miami, Florida · Recruiting
University of Miami Hospital and Clinics
Miami, Florida · Recruiting
Sylvester Comprehensive Cancer Center- Kendall
Miami, Florida · Recruiting
Sylvester Comprehensive Cancer Center - Sole Mia
North Miami, Florida · Recruiting
Hope and Healing Clinical Research
Hinsdale, Illinois · Recruiting
Hope and Healing Clinical Research
New Lenox, Illinois · Recruiting
Brigham and Women's Hospital
Boston, Massachusetts · Not yet recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts · Not yet recruiting
Dana-Farber Cancer Institute -Chestnut Hill
Newton, Massachusetts · Not yet recruiting
MSK Basking Ridge
Basking Ridge, New Jersey · Recruiting
MSK Monmouth
Middletown, New Jersey · Recruiting
MSK Bergen.
Montvale, New Jersey · Recruiting
MSK Commack
Commack, New York · Recruiting
MSK Westchester
Harrison, New York · Recruiting
Memorial Sloan Kettering Cancer Center - Investigational Drug Service Pharmacy
Long Island City, New York · Recruiting
Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street).
New York, New York · Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York · Recruiting
MSK Nassau
Uniondale, New York · Recruiting
University Hospitals Cleveland Medical Center
Cleveland, Ohio · Not yet recruiting
Westmead Hospital
Westmead, New South Wales, Australia · Recruiting
Calvary Connery Centre
Elizabeth Vale, South Australia, Australia · Recruiting
Warringal Private Hospital
Heidelberg, Victoria, Australia · Recruiting
Hospital São Lucas da PUCRS
Porto Alegre, Brazil · Recruiting
Hospital Sírio Libanês
São Paulo, Brazil · Recruiting
Centro Paulista de Oncologia Clínica
São Paulo, Brazil · Recruiting
Hospital Beneficência Portuguesa de São Paulo
São Paulo, São Paulo, Brazil · Recruiting
Showing 40 of 75 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.